Targeting cancer stem cells expressing an embryonic signature with anti-proteases to decrease their tumor potential
Cédric Darini(Jewish General Hospital), Annie Ladoux(Institut de Biologie Valrose)
Cited by 19
Related Papers
An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy
|Nature Communications|2019|64